Health Canada
www.hc-sc.gc.ca
Common menu bar links
Institutional links
Consumer Product Safety
Data Requirements for Use Site Category (USC # 15):
Indoor Hard Surfaces - End Use Products
Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section.
(PDF Version - 26 K)| Data Code | Title | Data required | Conditions | Volume No and Pages |
|---|---|---|---|---|
| 0 | Index | R | ||
| 1 | Label | R | ||
| 3 | Chemistry Requirements for the Registration of Manufacturing Concentrates and End-Use Products Formulated from Registered technical grade of active ingredients or integrated system products | |||
| 3.1 | Product Identification | |||
| 3.1.1 | Applicant's Name and Office Address | R | ||
| 3.1.2 | Formulating Plant's Name and Address | R | ||
| 3.1.3 | Trade Name | R | ||
| 3.1.4 | Other Names | R | ||
| 3.2 | Formulation Process | |||
| 3.2.1 | Description of Starting Materials | R | ||
| 3.2.2 | Description of the Formulation Process | R | ||
| 3.2.3 | Discussion of the Formation of Impurities of Toxicological Concern | CR | If applicable | |
| 3.3 | Specifications | |||
| 3.3.1 | Establishing Certified Limits | R | ||
| 3.3.2 | Control Product Specification Form | R | ||
| 3.4 | Product Analysis | |||
| 3.4.1 | Enforcement Analytical Method | R | ||
| 3.4.2 | Impurities of Toxicological Concern | CR | If applicable | |
| 3.5 | Chemical and Physical Properties | |||
| 3.5.1 | Colour | CR | Required for manufacturing concentrates only | |
| 3.5.2 | Physical State | R | ||
| 3.5.3 | Odour | CR | Required for manufacturing concentrates only | |
| 3.5.4 | Formulation Type | R | ||
| 3.5.5 | Container Material and Description | R | ||
| 3.5.6 | Density or Specific Gravity | R | ||
| 3.5.7 | pH | R | ||
| 3.5.8 | Oxidizing or Reducing Action (Chemical Incompatibility) | R | ||
| 3.5.9 | Viscosity | R | ||
| 3.5.10 | Storage Stability Data | R | ||
| 3.5.11 | Flammability | R | ||
| 3.5.12 | Explodability | R | ||
| 3.5.13 | Miscibility | R | ||
| 3.5.14 | Corrosion Characteristics | R | ||
| 3.5.15 | Dielectric Breakdown Voltage | R | ||
| 3.6 | Sample(s) | CR | If requested by PMRA | |
| 3.7 | Other Studies/Data/Reports | CR | If available | |
| 4 | Toxicology | |||
| 4.1 | Summaries | R | ||
| 4.6 | Acute Studies - EP | |||
| 4.6.1 | Acute Oral | R | ||
| 4.6.2 | Acute Dermal | R | ||
| 4.6.3 | Acute Inhalation | R | ||
| 4.6.4 | Primary Eye Irritation | R | ||
| 4.6.5 | Primary Dermal Irritation | R | ||
| 4.6.6 | Dermal Sensitization | R | ||
| 4.6.7 | Potentiation/Interaction | CR | If available | |
| 4.6.8 | Other Acute Studies | CR | If available | |
| 4.7 | Short-term Studies - EP | CR | Depending on use pattern, required if any component of the EP may increase absorption of the active ingredient(s) or increase toxic or pharmacologic effects | |
| 4.7.1 | Short-term Oral (90-day rodent) | CR | See 4.7 | |
| 4.7.2 | Short-term Oral (90-day and/or 12-month dog) | CR | See 4.7 | |
| 4.7.3 | Short-term Dermal (90-day) | CR | See 4.7 | |
| 4.7.4 | Short-term Dermal (21/28-day) | CR | See 4.7 | |
| 4.7.5 | Short-term Inhalation (21/28-day) | CR | See 4.7 | |
| 4.7.6 | Short-term Inhalation (90-day) | CR | See 4.7 | |
| 4.7.7 | Other Special Studies | CR | See 4.7 | |
| 4.8 | Other Studies/Data/Reports | CR | If available | |
| 5 | Exposure (Occupational and/or Bystander) | |||
| 5.1 | Summaries | R | ||
| 5.2 | Use Description/Scenario (Application and Post Application) | R | ||
| 5.4 | Mixer/Loader/Applicator- Passive Dosimetry Data | R | One of 5.4 or 5.5 | |
| 5.5 | Mixer/Loader/Applicator-Biological Monitoring Data | R | See 5.4 | |
| 5.8 | Dermal Absorption | CR | May be required if the margin of safety is inadequate | |
| 5.9 | Dislogeable Residues (Foliar, Soil and Surface) | CR | Required if there is potential for post application exposure | |
| 5.10 | Ambient Air Samples (Indoor - Outdoor) | CR | Required if there is potential for post application inhalation exposure | |
| 5.11 | Glove/Clothing Penetration Data | CR | May be required for risk mitigation purposes, or for inadequate margin of safety | |
| 5.13 | Package Integrity Study | CR | Required if packaged in water soluble bags | |
| 5.14 | Other Studies/Data/Reports | CR | If available | |
| 6 | Metabolism/Toxicokinetics Studies (TGAI or EP) | |||
| 6.1 | Summaries | |||
| 6.2 | Livestock | |||
| 6.3 | Plants | |||
| 6.4 | Other Studies/Data/Reports | CR | If available | |
| 7 | Food, Feed and Tobacco Residue Studies EP | |||
| 7.1 | Summaries | R | Input to assessment of toxicity to wildlife | |
| 7.2 | Analytical Methodology (Food Crops & Tobacco) | |||
| 7.2.1 | Supervised Residue Trial Analytical Methodology | R | ||
| 7.2.2 | Enforcement Analytical Methodology | R | ||
| 7.2.3 | Inter-laboratory Analytical Methodology Validation | R | ||
| 7.2.4 | Multi-residue Analytical Methodology Evaluation | R | ||
| 7.2.5 | Storage Stability of Working Solutions in Analytical Methodology | R | ||
| 7.3 | Freezer Storage Stability Tests | CR | Depends on length of storage | |
| 7.4 | Crop Residue Data | |||
| 7.4.1 | Supervised Residue Trial Study | |||
| 7.4.2 | Residue Decline Study | CR | Depends on size of crop | |
| 7.4.3 | Confined Crop Rotation Trial Study | |||
| 7.4.4 | Field Crop Rotation Trial Study | |||
| 7.4.5 | Processed Food/Feed | CR | ||
| 7.4.6 | Residue Data for Crops used as Livestock Feed (if needed for forage crops) | |||
| 7.5 | Livestock, Poultry, Egg and Milk Residue Data (from feeding of treated crops) | |||
| 7.6 | Livestock, Poultry, Egg and Milk Residue Data (external application) | |||
| 7.7 | Tobacco Residue Data | |||
| 7.8 | Other Studies/Data/Reports | CR | If available | |
| 10 | Value (applicable to each pest/site or host combination) | |||
| 10.1 | Value Summaries | R | ||
| 10.2 | Efficacy Studies | |||
| 10.2.1 | Mode of Action | R | ||
| 10.2.2 | Description of Pest Problem | R | ||
| 10.2.3 | Efficacy Trials | |||
| 10.2.3.1 | Summaries | R | ||
| 10.2.3.2 | Efficacy: Laboratory, Growth Chamber Trials | CR | ||
| 10.2.3.3 | Efficacy: Small-scale Trials (Field, Greenhouse) | R | One or both of 10.2.3.3 or 10.2.3.4 may be required | |
| 10.2.3.4 | Efficacy: Operational Trials | CR | See 10.2.3.4 | |
| 10.3 | Adverse Effects on Use Site | |||
| 10.3.1 | Summaries | R | ||
| 10.3.2 | Non-Safety Adverse Effects [e.g.: to crop, site of application (discoloration, corrosion), etc.] | R | ||
| 10.3.3 | Damage to Rotational Crops | CR | ||
| 10.4 | Economics | CR | ||
| 10.5 | Sustainability | |||
| 10.5.1 | Survey of Alternatives (chemical and non-chemical) | CR | ||
| 10.5.2 | Compatibility with Current Management Practices Including IPM | CR | ||
| 10.5.3 | Resistance Management | CR | ||
| 10.5.4 | Contribution to Risk Reduction | CR | ||
| 10.6 | Other Studies/Data/Reports | CR | If available | |
| 12.5 | Foreign Reviews | |||
| 12.5.3 | Foreign Reviews of Chemistry Requirements for MAs and EPs formulated from registered TGAIs or ISPs | |||
| 12.5.4 | Foreign Reviews of Toxicology | |||
| 12.5.5 | Foreign Reviews of Exposure (Occupational and/or Bystander) | |||
| 12.5.6 | Foreign Reviews of Metabolism / Toxicokinetics Studies | |||
| 12.5.7 | Foreign Reviews of Food, Feed and Tobacco Residue Studies | |||
| 12.5.10 | Foreign Reviews of Value | |||
| 12.7 | Comprehensive Data Summaries |
